Skip to Content

MFS Blended Research Value Equity R2 BRUKX

Medalist Rating as of | See MFS Investment Hub
  • NAV / 1-Day Return 16.02  /  0.00
  • Total Assets 286.6 Mil
  • Adj. Expense Ratio
    0.990%
  • Expense Ratio 0.990%
  • Distribution Fee Level Below Average
  • Share Class Type Retirement, Medium
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.91%
  • Turnover 51%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:14 PM GMT+0

Morningstar’s Analysis BRUKX

Will BRUKX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MFS Blended Research Value Equity R2’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BRUKX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

3.60 10.3 Mil
Financial Services

Johnson & Johnson

3.07 8.8 Mil
Healthcare

Wells Fargo & Co

2.32 6.6 Mil
Financial Services

Berkshire Hathaway Inc Class B

2.06 5.9 Mil
Financial Services

The Cigna Group

1.85 5.3 Mil
Healthcare

Salesforce Inc

1.85 5.3 Mil
Technology

Pfizer Inc

1.71 4.9 Mil
Healthcare

Phillips 66

1.71 4.9 Mil
Energy

Applied Materials Inc

1.65 4.7 Mil
Technology

Chubb Ltd

1.61 4.6 Mil
Financial Services